TTF1 Expression in Non-Small Cell Lung Carcinoma: Association with TTF1 Gene Amplification and Improved Survival

被引：0
|
作者：
Wagner, P. L.
Perner, S.
Solterman, A.
LaFargue, C. L.
Tischler, V.
Weir, B. A.
Weder, W.
Meyerson, M.
Giordano, T. J.
Moch, H.
Rubin, M. A.
机构：
[1] Cornell Univ, Weill Med Coll, New York, NY 10021 USA
[2] Univ Zurich Hosp, CH-8091 Zurich, Switzerland
[3] Univ Zurich, Zurich, Switzerland
[4] Univ Michigan, Ann Arbor, MI 48109 USA
[5] Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
MODERN PATHOLOGY | 2009年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1648
引用
收藏
页码：363A / 363A
页数：1
相关论文
共 50 条
  • [11] The role of TTF1 as prognostic factor in stage III non-small cell lung cancer (NSCLC)
    Berghmans, T.
    Mascaux, C.
    Martin, B.
    Sculier, J. P.
    EJC SUPPLEMENTS, 2005, 3 (02): : 341 - 341
  • [12] TTF1 negative in non small cell lung cancer adenocarcinoma: A prognostic factor
    Cordoba, Juan F.
    Morales, Serafin
    Veas, Joel
    Rodriguez, Alvaro
    Reguart, Noemi
    Salud, Antonieta
    CANCER RESEARCH, 2019, 79 (13)
  • [13] TTF1 Expression in Advanced Lung Adenocarcinoma and Survival Outcome: An Observational Study
    Webster, R.
    Mccann, K.
    Facey, M.
    Faisal, W.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1166 - S1166
  • [14] TTF1 negative in non small cell lung cancer adenocarcinoma: A prognostic factor.
    Felipe Cordoba, Juan
    Morales, Serafin
    Veas Rodriguez, Joel
    Rodriguez Galindo, Alvaro
    Salud, Antonia
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [15] Clinical and pathological features and prognosis of non-small cell lung cancer (NSCLC) patients with adenocarcinomas without TTF1 and Napsin A expression
    Kraus, F.
    Nilius, G.
    Boeluekbas, S.
    Stoever, I.
    Koziorowski, A.
    Grabellus, F.
    Christoph, D. C.
    ANNALS OF ONCOLOGY, 2021, 32 : S1231 - S1231
  • [16] TTF1 Expression in Pulmonary Metastatic Rectal Adenocarcinoma
    Aversa, Sara
    Bellan, Cristiana
    CASE REPORTS IN GASTROINTESTINAL MEDICINE, 2018, 2018
  • [17] Clinical and pathological features and prognosis of non-small cell lung cancer (NSCLC) patients with adenocarcinomas without TTF1 and Napsin A expression
    Kraus, Franziska
    Nilius, Georg
    Boeluekbas, Servet
    Stoever, Imke
    Koziorowski, Andreas
    Grabellus, Florian
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 3) : 155 - 155
  • [18] Clinical and pathological features and prognosis of non-small cell lung cancer (NSCLC) patients with adenocarcinomas without TTF1 and Napsin A expression
    Kraus, F.
    Nilius, G.
    Boeluekbas, S.
    Stoever, I
    Koziorowski, A.
    Grabellus, F.
    Christoph, D.
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 172 - 172
  • [19] Comparative histopathological and digital scoring between microfluidic and standard immunohistochemistry for p40 and TTF1 on non-small cell lung carcinoma
    Procopio, M.
    Houmani, M.
    Brajkovic, S.
    Leblond, A.
    Dupouy, D. G.
    Soltermann, A.
    VIRCHOWS ARCHIV, 2020, 477 : S124 - S124
  • [20] TUMOR EXPRESSION OF TTF1 IS ASSOCIATED WITH A DOUBLING OF OVERALL SURVIVAL IN PATIENTS WITH ADVANCED LUNG ADENOCARCINOMAS
    Hellmann, Matthew D.
    Hilden, Patrick D.
    Sima, Camelia S.
    Kris, Mark G.
    Rekhtman, Natasha
    Chaft, Jamie E.
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S497 - S498
12345